Your search returned 3 results.

Sort
Results
1.
The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012-2019. MedStar authors:
  • Shorr, Andrew F
PMID:
  • 36199012
Year: 2022
Citation:
  • BMC Infectious Diseases. 22(1):775, 2022 Oct 05.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Pulmonary-Critical Care
Medline publication type:
  • Journal Article
  • Multicenter Study
Form of publication:
  • Journal Article
All authors:
  • Dillon RJ, Nathanson BH, Puzniak LA, Shorr AF, Zilberberg MD
2.
Issues in antibiotic therapy for hospital-acquired and ventilator-associated pneumonia: emerging concepts to improve outcomes. MedStar authors:
  • Mahmood, Syed Nazeer
  • Shorr, Andrew F
PMID:
  • 33764852
Year: 2021
Citation:
  • Expert Opinion on Pharmacotherapy. 22(12):1547-1553, 2021 Aug.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Pulmonary-Critical Care
  • Pulmonary/Critical Care Fellowship
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Mahmood SN, Shorr AF
3.
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019. MedStar authors:
  • Shorr, Andrew F
PMID:
  • 35322770
Year: 2022
Citation:
  • Infection Control & Hospital Epidemiology. 43(3):277-283, 2022 03.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Pulmonary-Critical Care
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Nathanson BH, Puzniak LA, Shorr AF, Zilberberg MD
Pages

Powered by Koha